AS 50 mg / AQ eq. 135mg base, blister of 3 tab, 9-17 kg
STD
DORAASAQ2T1
Valid Article
Account code:
60000
HS Code:
300460
Last Updated on:
11/07/2024, 22:02:32
Former
Code(s):
DORAARAC02-
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF03
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
ARTESUNATE (AS)/ AMODIAQUINE (AQ)
Therapeutic Action
Fixed-dose combination (FDC) of two antimalarials
Indications
Instructions for use
4 different presentations for 4 categories of weight:
- infants 4.5-8 kg (2-11 months) : blister of 3 tab. (25/67.5mg)
- toddlers 9-17 kg (1-5 years): blister of 3 tab. (50/135 mg)
- children 18-35 kg (6-13 years): blister of 3 tab. (100/270 mg)
- adults > 36 kg (14 and over): blister of 6 tab. (100/270 mg)
The quantity to be ordered is calculated per blister (= one treatment), not per tablet.
Storage
Below 25°C